In a crossover trial of 39 patients with Alzheimer’s disease, treatment with nabilone (a synthetic THC analog) was associated with significant improvement in agitation and, remarkably, cognition. Further studies should examine the effects of both THC and CBD in patients with Alzheimer’s disease because anxiety is common in dementia and may exacerbate agitation.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2IH2BfX inside the CED Foundation Archive
To explore related information, click the keywords below: